This session will provide attendees with a detailed understanding of eligibility criteria, funding amounts, and common misconceptions regarding financial incentives for the pharmaceutical industry. Participants will also gain insights into future grants and funding programmes that have yet to be officially announced. The webinar will include dedicated Q&A sessions via Slido, allowing for direct engagement with government representatives. Open to MOPI members, non-members, and select stakeholders, this session is a valuable opportunity for industry players to maximise available financial support.

Download the agenda here

Note: Agenda is subject to change. 

• This event is NOT HRDCorp claimable.

• No refund is allowed. 

• After payment, please wait 48 hours for the meeting link to be shared with the registered email.

• Receipts for payments will be provided after the event date.

  • For online banking (FPX) payments via Ticket2U, receipts will be generated automatically.
  • For invoice payments, receipts will be issued after the event.

• E-certificates will be issued only to registered names after the event date. No changes to the name will be allowed after registration.

• Speakers' presentation slides will be shared after the event date.

• Please join the session 15 minutes before the start time to allow Zoom to set up your user interface, if needed.

• To ensure a smooth webinar experience:

  • Participants' microphones will be muted, and video cameras will be disabled.
  • All Q&A sessions will be conducted through Slido. The host will provide more information on using Slido on the event day.
• For chambers/industry associations registering under this category, eligibility is limited to board/exco members and the secretariat. When registering, please specify your designation within the chamber/industry association rather than the company you represent.

• The organiser reserves the right to adjust the agenda, reschedule the date and time if necessary, and review participant registrations to ensure accuracy and validity.